Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Precise coordination of the S and M phases of the eukaryotic cell cycle is critical not only for normal cell division, but also for effective growth arrest under conditions of stress. When damaged, a cell must communicate signals to both the mitotic and DNA synthesis machineries so that a mitotic block is not followed by an extra S phase, or vice versa. The biochemical mechanisms regulating this coordination, termed checkpoints, have been identified in lower eukaryotes, but are largely unknown in mammalian cells. Here we show that p21 WAF1/CIP1, the prototype inhibitor of cyclin-dependent kinases (CDKs), is required for this coordination in human cells. In the absence of p21, DNA-damaged cells arrest in a G2-like state, but then undergo additional S phases without intervening normal mitoses. They thereby acquire grossly deformed, polyploid nuclei and subsequently die through apoptosis. Perhaps not by coincidence, the DNA-damaging agents that can cause S/M uncoupling are used in the clinic to kill cancer cells preferentially.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Indeed, after transiently arresting in G2, HCT-116 cells in which p21 was knocked out eventually underwent aberrant mitoses, leading to polyploidy or cell death.53,55”
From Senescence from G2 arrest, revisited (2015) · cites this paper as [53]
Citations
Cites
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.
Gavrieli, Y., Sherman, Y., & Ben-Sasson, S. A. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.3.493 · Cited by 9,444
Hartwell, L. H., & Kastan, M. B. (1994) · Science · doi:10.1126/science.7997877 · Cited by 2,535
Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., & Giaccia, A. J. (1996) · Nature · doi:10.1038/379088a0 · Cited by 2,300
Di Leonardo, A., Linke, S. P., Clarkin, K., & Wahl, G. M. (1994) · Genes & Development · doi:10.1101/gad.8.21.2540 · Cited by 1,215
p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage.
Macleod, K. F., Sherry, N., Hannon, G., Beach, D., Tokino, T., Kinzler, K., Vogelstein, B., & Jacks, T. (1995) · Genes & Development · doi:10.1101/gad.9.8.935 · Cited by 1,119
Self-citationGorczyca, W., GONG, J., & Darżynkiewicz, Z. (1993) · PubMed · Cited by 982
Creative blocks: cell-cycle checkpoints and feedback controls
Murray, A. W. (1992) · Nature · doi:10.1038/359599a0 · Cited by 663
A p53-Dependent Mouse Spindle Checkpoint
Cross, S. M., Sanchez, C. A., Morgan, C. A., Schimke, M. K., Ramel, S., Idzerda, R. L., Raskind, W. H., & Reid, B. J. (1995) · Science · doi:10.1126/science.7871434 · Cited by 660
Ordering S phase and M phase in the cell cycle
Nurse, P. (1994) · Cell · doi:10.1016/0092-8674(94)90539-8 · Cited by 589
Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues.
El‐Deiry, W. S., Tokino, T., Waldman, T. A., Oliner, J., Velculescu, V. E., Burrell, M., HILL, D. E., Healy, E., Rees, J. L., & Hamilton, S. R. (1995) · PubMed · Cited by 582
Self-citation
Research works printed but not linked: 8
- Waldman, T., Kinzler, K. W. & Vogelstein, B. Cancer Res. 55, 5187–5190 (1995).
- Gorczyca, W., Gong, J. & Darzynkiewicz, Z. Cancer Res. 53, 1945–1951 (1993).
- Gao, X. et al. Oncogene 11, 1395–1398 (1995).
- El-Deiry, W. A. et al. Cancer Res. 55, 2910–2919 (1995).
- Kung, A. L., Zetterberg, A., Sherwood, S. W. & Schimke, R. T. Cancer Res. 50, 7307–7317 (1990).
- Carder, P. et al. Oncogene 8, 1397–1401 (1993).
- Harvey, M. et al. Oncogene 8, 2457–2467 (1993).
- Morrow, C. S. & Cowan, K. H. in Cancer Medicine (eds Holland, J. F. et al.), 618–631 (Lea & Febiger, Philadelphia, 1993).
Cited by
Items 101–200 of 727
POLYPLOID GIANT CELLS PROVIDE A SURVIVAL MECHANISM FOR p53 MUTANT CELLS AFTER DNA DAMAGE
Illidge, T. M., Cragg, M. S., Fringes, B., Olive, P., & Erenpreisa, J. A. (2000) · Cell Biology International · doi:10.1006/cbir.2000.0557 · Cited by 169
Boswellic acids and malignant glioma: induction of apoptosis but no modulation of drug sensitivity
Glaser, T., Winter, S., Groscurth, P., Safayhi, H., Sailer, E.-R., Ammon, H. P. T., Schabet, M., & Weller, M. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690419 · Cited by 164
Human Papillomavirus Oncoproteins E6 and E7 Independently Abrogate the Mitotic Spindle Checkpoint
Thomas, J. T., & Laimins, L. A. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1131-1137.1998 · Cited by 162
Shcherbata, H. R., Althauser, C., Findley, S. D., & Ruohola-Baker, H. (2004) · Development · doi:10.1242/dev.01172 · Cited by 159
Sankala, H. M., Hait, N. C., Paugh, S. W., Shida, D., Lépine, S., Elmore, L. W., Dent, P., Milstien, S., & Spiegel, S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2090 · Cited by 161
Differential regulation of p53 and p21 by MKRN1 E3 ligase controls cell cycle arrest and apoptosis
Lee, E., Lee, M., Camus, S., Ghim, J., Yang, M., Oh, W., Ha, N., Lane, D. P., & Song, J. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.164 · Cited by 160
Mahyar-Roemer, M., & Roemer, K. (2001) · Oncogene · doi:10.1038/sj.onc.1204440 · Cited by 162
Tbx2 Directly Represses the Expression of the p21WAF1 Cyclin-Dependent Kinase Inhibitor
Prince, S., Carreira, S., Vance, K. W., Abrahams, A., & Goding, C. R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3286 · Cited by 160
Hzf Determines Cell Survival upon Genotoxic Stress by Modulating p53 Transactivation
Das, S., Raj, L., Zhao, B., Kimura, Y., Bernstein, A., Aaronson, S. A., & Lee, S. W. (2007) · Cell · doi:10.1016/j.cell.2007.06.013 · Cited by 158
Chemotherapy-Induced Apoptosis
Mesner, P. W., Budihardjo, I. I., & Kaufmann, S. H. (1997) · Advances in Pharmacology · doi:10.1016/s1054-3589(08)61069-8 · Cited by 158
Blalock, W., Weinstein-Oppenheimer, C., Chang, F., Hoyle, P., Wang, X.-Y., Algate, P., Franklin, R., Oberhaus, S., Steelman, L., & McCubrey, J. (1999) · Leukemia · doi:10.1038/sj.leu.2401493 · Cited by 158
Exploiting cancer cell cycling for selective protection of normal cells.
Blagosklonny, M. V., & Pardee, A. B. (2001) · PubMed · Cited by 199
The G2/M Regulator 14-3-3ς Prevents Apoptosis through Sequestration of Bax
Samuel, T., Weber, H. O., Rauch, P., Verdoodt, B., Eppel, J.-T., McShea, A., Hermeking, H., & Funk, J. O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106427200 · Cited by 155
Regulation of apoptosis by PML and the PML-NBs
Bernardi, R., Papa, A., & Pandolfi, P. P. (2008) · Oncogene · doi:10.1038/onc.2008.305 · Cited by 177
AP4 encodes a c-MYC-inducible repressor of p21
Jung, P., Menssen, A., Mayr, D., & Hermeking, H. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801773105 · Cited by 153
Kominami, K., & Toda, T. (1997) · Genes & Development · doi:10.1101/gad.11.12.1548 · Cited by 151
Dissecting the pathways to death
Daniel, P. (2000) · Leukemia · doi:10.1038/sj.leu.2401940 · Cited by 165
Smith, N. D., Rubenstein, J. N., Eggener, S. E., & Kozlowski, J. M. (2003) · The Journal of Urology · doi:10.1097/01.ju.0000056085.58221.80 · Cited by 172
Itzhaki, J. E., Gilbert, C., & Porter, A. (1997) · Nature Genetics · doi:10.1038/ng0397-258 · Cited by 163
Baptiste, N., Friedlander, P. A., Chen, X., & Prives, C. L. (2002) · Oncogene · doi:10.1038/sj.onc.1205015 · Cited by 168
Yang, W., Mathew, J., Velcich, A., Edelmann, W., Kucherlapati, R., Lipkin, M., Yang, K., & Augenlicht, L. H. (2001) · PubMed · Cited by 164
Mitochondrial respiration protects against oxygen-associated DNA damage
Sung, H. J., Ma, W., Wang, P.-Y., Hynes, J., O'Riordan, T. C., Combs, C. A., McCoy, J. P., Bunz, F., Kang, J.-G., & Hwang, P. M. (2010) · Nature Communications · doi:10.1038/ncomms1003 · Cited by 144
Sancho, E., Vilá, M. R., Sánchez-Pulido, L., Lozano, J. J., Paciucci, R., Nadal, M., Fox, M., Harvey, C., Bercovich, B., Loukili, N., et al. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.1.576 · Cited by 144
Tai, I. T., Dai, M., Owen, D. A., & Chen, L. B. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23002 · Cited by 142
DNA damage induces two distinct modes of cell death in ovarian carcinomas
Vakifahmetoglu, H., Olsson, M., Tamm, C., Heidari, N., Orrenius, S., & Zhivotovsky, B. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402286 · Cited by 157
Wang, Y., Blandino, G., & Givol, D. (1999) · Oncogene · doi:10.1038/sj.onc.1202632 · Cited by 144
CDK8/19 Mediator kinases potentiate induction of transcription by NFκB
Chen, M., Liang, J., Ji, H., Yang, Z., Altilia, S., Hu, B., Schronce, A., McDermott, M. S. J., Schools, G. P., Lim, C.-U., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1710467114 · Cited by 139
Cholesterol is essential for mitosis progression and its deficiency induces polyploid cell formation
Fernández, C., Toledo-Lobo, M. V., Gómez‐Coronado, D., & Lasunción, M. A. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.06.029 · Cited by 141
Disruption of Trrap causes early embryonic lethality and defects in cell cycle progression
Herceg, Z., Hulla, W., Gell, D., Cuenin, C., Lleonart, M., Jackson, S., & Wang, Z.-Q. (2001) · Nature Genetics · doi:10.1038/ng725 · Cited by 139
Coupling of Mitosis to the Completion of S Phase Through Cdc34-Mediated Degradation of Wee1
Michael, W. M. (1998) · Science · doi:10.1126/science.282.5395.1886 · Cited by 137
C-myc overexpression and p53 loss cooperate to promote genomic instability
Yin, X.-Y., Grove, L. E., Datta, N. S., Long, M. W., & Prochownik, E. V. (1999) · Oncogene · doi:10.1038/sj.onc.1202410 · Cited by 149
Shu, L., Yan, W., & Chen, X. (2006) · Genes & Development · doi:10.1101/gad.1463306 · Cited by 144
Korver, W., Schilham, M. W., Moerer, P., van den Hoff, M. J. B., Dam, K. V., Lamers, W. H., Medema, R. H., & Clevers, H. C. (1998) · Current Biology · doi:10.1016/s0960-9822(07)00563-5 · Cited by 148
Crystal Structure and Mutagenic Analysis of the Inhibitor-of-Apoptosis Protein Survivin
Muchmore, S. W., Chen, J., Jakob, C. G., Zakula, D., Matayoshi, E. D., Wu, W., Zhang, H., Li, F., Ng, S., & Altieri, D. C. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00018-6 · Cited by 132
Phosphorylation of p21 in G2/M Promotes Cyclin B-Cdc2 Kinase Activity
Dash, B. C., & El‐Deiry, W. S. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.8.3364-3387.2005 · Cited by 160
Mitotic death: a mechanism of survival? A review
Erenpreisa, J. A., & Cragg, M. S. (2001) · Cancer Cell International · doi:10.1186/1475-2867-1-1 · Cited by 145
Rau, B., Sturm, I., Lage, H., Berger, S. M., Schneider, U., Hauptmann, S., Wust, P., Riess, H. B., Schlag, P. M., Dörken, B., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.07.077 · Cited by 155
Vogt, B. L., & Rossman, T. G. (2001) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(01)00137-3 · Cited by 137
Tian, H., Wittmack, E. K., & Jorgensen, T. J. (2000) · PubMed · Cited by 125
Liu, S., Edgerton, S. M., Moore, D. H., & Thor, A. D. (2001) · PubMed · Cited by 122
DNA damage and cell cycle checkpoints in hyperoxic lung injury: braking to facilitate repair
O'Reilly, M. A. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.281.2.l291 · Cited by 122
Cellular effects of CPT‐11 on colon carcinoma cells: Dependence on p53 and hMLH1 status
Magrini, R., Bhonde, M. R., Hanski, M., Notter, M., Scherübl, H., Boland, C. R., Zeitz, M., & Hanski, C. (2002) · International Journal of Cancer · doi:10.1002/ijc.10565 · Cited by 121
p53 induces TAP1 and enhances the transport of MHC class I peptides
Zhu, K., Wang, J., Zhu, J., Jiang, J., Shou, J., & Chen, X. (1999) · Oncogene · doi:10.1038/sj.onc.1203235 · Cited by 127
Wächtershäuser, A., Akoglu, B., & Stein, J. M. (2001) · Carcinogenesis · doi:10.1093/carcin/22.7.1061 · Cited by 123
Uncoupling p53 Functions in Radiation-Induced Intestinal Damage via PUMA and p21
Leibowitz, B. J., Qiu, W., Liu, H., Cheng, T., Zhang, L., & Yu, J. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0052 · Cited by 132
Kawamura, I., Morishita, R., Tomita, N., Lacey, E., Aketa, M., Tsujimoto, S., Manda, T., Tomoi, M., Kida, I., Higaki, J., et al. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300819 · Cited by 117
Motwani, M., Jung, C. P., Sirotnak, F. M., She, Y., Shah, M. A., Gönen, M., & Schwartz, G. K. (2001) · PubMed · Cited by 116
Sepp‐Lorenzino, L., & Rosen, N. X. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20243 · Cited by 120
Ashcroft, G. S., Herrick, S. E., Tarnuzzer, R. W., Horan, M. A., Schultz, G. S., & Ferguson, M. W. J. (1997) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199710)183:2<169::aid-path915>3.0.co;2-q · Cited by 121
Less understood issues: p21Cip1 in mitosis and its therapeutic potential
Kreis, N., Louwen, F., & Yuan, J. (2014) · Oncogene · doi:10.1038/onc.2014.133 · Cited by 129
Schmitt, E., Paquet, C., Beauchemin, M., & Bertrand, R. (2007) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.2007.b0377 · Cited by 150
Mitchell, K. O., & El‐Deiry, W. S. (1999) · PubMed · Cited by 114
Andreassen, P. R., Lacroix, F., Lohez, O. D., & Margolis, R. L. (2001) · PubMed · Cited by 131
Distinct mechanisms act in concert to mediate cell cycle arrest
Toettcher, J. E., Loewer, A., Ostheimer, G. J., Yaffe, M. B., Tidor, B., & Lahav, G. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806196106 · Cited by 112
“Consistent with our modeling results and previous reports (29), approximately half of the p21 / population had DNA content greater than 4N (Fig.”
BackgroundResultBlagosklonny, M. V., Robey, R., Bates, S., & Fojo, T. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8625 · Cited by 112
Javelaud, D., & Besançon, F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204497200 · Cited by 135
Molecular characteristics of non-small cell lung cancer
Nacht, M., Dracheva, T., Gao, Y., Fujii, T., Chen, Y., Player, A. N., Akmaev, V. R., Cook, B. P., Dufault, M. R., Zhang, M., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.261414598 · Cited by 127
Effect of p53 Status on Sensitivity to Platinum Complexes in a Human Ovarian Cancer Cell Line
Pestell, K. E., Hobbs, S. M., Titley, J. C., Kèlland, L. R., & Walton, M. I. (2000) · Molecular Pharmacology · doi:10.1124/mol.57.3.503 · Cited by 113
p130/E2F4 Binds to and Represses the cdc2 Promoter in Response to p53
Taylor, W. R., Schönthal, A. H., Galante, J., & Stark, G. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005101200 · Cited by 110
The Molecular Basis of Canine Melanoma: Pathogenesis and Trends in Diagnosis and Therapy
Modiano, J. F., Ritt, M. G., & Wojcieszyn, J. W. (1999) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.1999.tb02173.x · Cited by 122
Tumour suppressor genes in chemotherapeutic drug response
Lai, D., Grieve, S., & Yang, X. (2012) · Bioscience Reports · doi:10.1042/bsr20110125 · Cited by 126
Lincet, H., Poulain, L., Rémy, J.-S., Deslandes, E., Duigou, F., Gauduchon, P., & Staedel, C. (2000) · Cancer Letters · doi:10.1016/s0304-3835(00)00586-3 · Cited by 124
Krüppel-like factor 4 exhibits antiapoptotic activity following γ-radiation-induced DNA damage
Ghaleb, A. M., Katz, J. P., Kaestner, K. H., Du, J. X., & Yang, V. W. (2006) · Oncogene · doi:10.1038/sj.onc.1210022 · Cited by 125
Bertolini, F., Bengala, C., Losi, L., Pagano, M., Iachetta, F., Dealis, C., Jovic, G., Depenni, R., Zironi, S., Falchi, A., et al. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.02.018 · Cited by 107
Negative cross‐talk between p53 and the glucocorticoid receptor and its role in neuroblastoma cells
Sengupta, S., Vonesch, J., Waltzinger, C., Zheng, H., & Wasylyk, B. (2000) · The EMBO Journal · doi:10.1093/emboj/19.22.6051 · Cited by 121
Canman, C. E., & Kastan, M. B. (1997) · Advances in pharmacology · doi:10.1016/s1054-3589(08)61068-6 · Cited by 115
neu/ERBB2 Cooperates with p53-172H during Mammary Tumorigenesis in Transgenic Mice
Li, B., Rosen, J. M., McMenamin-Balano, J., Muller, W. J., & Perkins, A. S. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.6.3155 · Cited by 105
Ivanov, A., Cragg, M. S., Erenpreisa, J. A., Emzinsh, D., Lukman, H., & Illidge, T. (2003) · Journal of Cell Science · doi:10.1242/jcs.00740 · Cited by 123
Gorospe, M., Wang, X., & Holbrook, N. J. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.3.1400 · Cited by 104
Casenghi, M., Mangiacasale, R., Tuynder, M., Caillet-Fauquet, P., Elhajouji, A., Lavia, P., Mousset, S., Kirsch‐Volders, M., & Cundari, E. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4554 · Cited by 117
Radiation-Induced p53 and p21WAF–1/CIP1 Expression in the Murine Intestinal Epithelium
Wilson, J. W., Pritchard, D. M., Hickman, J. A., & Potten, C. S. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65631-3 · Cited by 112
Stewart, Z. A., Mays, D. J., & Pietenpol, J. A. (1999) · PubMed · Cited by 121
Role of Human Cds1 (Chk2) Kinase in DNA Damage Checkpoint and Its Regulation by p53
Tominaga, K., Morisaki, H., Kaneko, Y., Fujimoto, A., Tanaka, T., Ohtsubo, M., Hirai, M., Okayama, H., Ikeda, K., & Nakanishi, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.44.31463 · Cited by 99
A negative genetic interaction map in isogenic cancer cell lines reveals cancer cell vulnerabilities
Vizeacoumar, F. J., Arnold, R., Vizeacoumar, F. S., Chandrashekhar, M., Buzina, A., Young, J. T. F., Kwan, J. H. M., Sayad, A., Mero, P., Lawo, S., et al. (2013) · Molecular Systems Biology · doi:10.1038/msb.2013.54 · Cited by 98
Acquired resistance to combined BET and CDK4/6 inhibition in triple-negative breast cancer
Ge, J. Y., Shu, S., Kwon, M., Jovanović, B., Murphy, K. C., Gulvady, A. C., Fassl, A., Trinh, A., Kuang, Y., Heavey, G. A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16170-3 · Cited by 114
Chu, K., Teele, N., Dewey, M. W., Albright, N., & Dewey, W. C. (2004) · Radiation Research · doi:10.1667/rr3221 · Cited by 120
Zhu, J., & Chen, X. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.15.5602-5618.2000 · Cited by 98
Romanov, S., Medvedev, A. V., Gambarian, M., Poltoratskaya, N., Moeser, M., Medvedeva, L., Gambarian, M., Diatchenko, L. B., & Makarov, S. S. (2008) · Nature Methods · doi:10.1038/nmeth.1186 · Cited by 106
Utrera, R., Collavin, L., Lazarević, D., Delia, D., & Schneider, C. (1998) · The EMBO Journal · doi:10.1093/emboj/17.17.5015 · Cited by 115
Arresting developments in the cardiac myocyte cell cycle: Role of cyclin-dependent kinase inhibitors
Brooks, G., Poolman, R. A., & Li, J. M. (1998) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00125-4 · Cited by 113
p53-dependent gene repression through p21 is mediated by recruitment of E2F4 repression complexes
Benson, E. K., Mungamuri, S. K., Attie, O., Kracikova, M., Sachidanandam, R., Manfredi, J. J., & Aaronson, S. A. (2014) · Oncogene · doi:10.1038/onc.2013.378 · Cited by 96
Melton, D. W., Ketchen, A.-M., Núñez, F., Bonatti-Abbondandolo, S., Abbondandolo, A., Squires, S., & Johnson, R. T. (1998) · Journal of Cell Science · doi:10.1242/jcs.111.3.395 · Cited by 95
An overview of the cell cycle arrest protein, p21WAF1
Harada, K., & Ogden, G. R. (2000) · Oral Oncology · doi:10.1016/s1368-8375(99)00049-4 · Cited by 94
Polycomb protein EZH2 regulates cancer cell fate decision in response to DNA damage
Wu, Z., Lee, S. T., Qiao, Y., Li, Z., Lee, P. L., Lee, Y. J., Jiang, X., Tan, J. Y., Aau, M., Lim, C. Z. H., et al. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.48 · Cited by 95
N. YAMAGISHI, J. M. A. H. T. (1997) · International Journal of Radiation Biology · doi:10.1080/095530097143374 · Cited by 95
Chen, Y., Chiang, S., Lin, J., Yang, J., Ma, Y., Liao, C., Lai, T.-Y., Tang, N.-Y., & Chung, J. (2010) · PubMed · Cited by 100
Selective sensitivity to radiation of cerebral glioblastomas harboring p53 mutations.
Tada, M., Matsumoto, R., Iggo, R. D., Onimaru, R., Shirato, H., Sawamura, Y., & Shinohe, Y. (1998) · PubMed · Cited by 99
Helt, A.-M., Funk, J. O., & Galloway, D. A. (2002) · Journal of Virology · doi:10.1128/jvi.76.20.10559-10568.2002 · Cited by 90
Do heat stress and deficits in DNA repair pathways have a negative impact on male fertility?
Paul, C., Melton, D. W., & Saunders, P. T. K. (2008) · Molecular Human Reproduction · doi:10.1093/molehr/gam089 · Cited by 94
CD44 promotes resistance to apoptosis in human colon cancer cells
Lakshman, M., Subramaniam, V., Rubenthiran, U., & Jothy, S. (2004) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2004.03.002 · Cited by 75
The Involvement of MAPK Signaling Pathways in Determining the Cellular Response to p53 Activation
Brown, L. M., & Benchimol, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507951200 · Cited by 99
Clark, D., Mitra, A., Fillmore, R., Jiang, W., Samant, R., Fodstad, O., & Shevde, L. (2008) · Current Cancer Drug Targets · doi:10.2174/156800908785133196 · Cited by 89
Induction of cell cycle arrest by the endogenous product of lipid peroxidation, malondialdehyde
Ji, C., Rouzer, C. A., Marnett, L. J., & Pietenpol, J. A. (1998) · Carcinogenesis · doi:10.1093/carcin/19.7.1275 · Cited by 100
Li, Z., Xia, L., Lee, L. M., Khaletskiy, A., Wang, J., Wong, J. Y. C., & Li, J. J. (2001) · Radiation Research · doi:10.1667/0033-7587(2001)155[0543:egaimh]2.0.co;2 · Cited by 97
NAD+ Modulates p53 DNA Binding Specificity and Function
McLure, K. G., Takagi, M., & Kastan, M. B. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.22.9958-9967.2004 · Cited by 88
Eymin, B., Haugg, M., Droin, N. M., Sordet, O., Dimanche‐Boitrel, M., & Solary, É. (1999) · Oncogene · doi:10.1038/sj.onc.1202437 · Cited by 89
Inhibition of tumor cell proliferation by thieno[2,3-d]pyrimidin-4(1H)-one-based analogs
Wang, Y. D., Johnson, S., Powell, D. W., McGinnis, J. P., Miranda, M., & Rabindran, S. K. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.05.127 · Cited by 87
Molecular markers for bladder cancer: the road to a multimarker approach
Birkhahn, M., Mitra, A. P., & Côté, R. J. (2007) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.7.12.1717 · Cited by 88
Lee, J. Y., Yu, S. J., Park, Y. G., Kim, J., & Sohn, J. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01461-06 · Cited by 85
Ukomadu, C., & Dutta, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307194200 · Cited by 84
Metadata
- Authors
- Waldman, T., Lengauer, C., Kinzler, K. W., & Vogelstein, B.
- Affiliations
- Howard Hughes Medical Institute (US)
- Venue
- Nature
- Published
- 1996-06
- Volume
- 381
- Issue
- 6584
- Pages
- 713-716
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2008117987
- Cited by
- 728
- References
- 28
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 2 · 2023: 10 · 2022: 1 · 2021: 6 · 2020: 6 · 2019: 4 · 2018: 12 · 2017: 5 · 2016: 11 · 2015: 5 · 2014: 8 · 2013: 10 · 2012: 18
- FWCI
- 32.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Keywords
- p21, cell cycle checkpoints, cyclin-dependent kinases, DNA damage response, polyploidy, apoptosis, anticancer agents, cell cycle coordination
- MeSH terms
- Antineoplastic Agents, Camptothecin, DNA Damage, Doxorubicin, Enzyme Inhibitors, Etoposide, Fluorescent Dyes, Gamma Rays, Bisbenzimidazole, Humans, Mitosis, Tumor Cells, Cultured, S Phase, Cyclins, Apoptosis, Cyclin-Dependent Kinases, Cyclin-Dependent Kinase Inhibitor p21
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.